News

RotaFlash, December 2012

On December 6, Tanzania simultaneously launched vaccines against the primary causes of two of the leading childhood killers in Tanzania and worldwide – pneumonia and diarrhea. The launch took place in tandem with the GAVI Alliance Partners Forum, at which global experts and country leaders explored approaches to accelerate lives saved through immunization.

Read the full article.

PATH press release, November 2012

With a new grant from the Starbucks Foundation, PATH will address water, sanitation, and hygiene in coffee-growing communities in Tanzania.

Read the full press release.

Herald Online, November 2012

PATH’s Drug Development program announced today the completion of two phase 1 clinical studies for iOWH032—its investigational new drug to treat acute diarrhea caused by diseases such as cholera. Based on positive outcomes, iOWH032 will proceed into the next phase of clinical trials in Bangladesh in early 2013.

Read the full article

Read more here: http://www.heraldonline.com/2012/11/12/4407181/paths-drug-development-program.html#storylink=cpy

AllAfrica.com, November 2012

A group of dedicated partners has completed a pilot rollout of rotavirus vaccines throughout Zambia's Lusaka Province. The vaccine is provided in an integrated clinical package that also encourages use of ORS and zinc for treatment and prevention, along with education about nutrition and hygiene.

Read the full article.

PATH RotaFlash, October 2012

On October 29, rotavirus vaccines continued their historic roll-out across Africa, as Malawi became the fourth GAVI-eligible African country to introduce the vaccines for use in the routine immunization program. Malawi has played a pivotal role in the development of rotavirus vaccines worldwide, taking part in an important study that demonstrated the vaccines' efficacy in low-resource, high-burden settings.

Read the full article.

PATH RotaFlash, October 2012

Existing age restrictions prevent rotavirus vaccination of many children who are most vulnerable, particularly in poor settings where children often present late for routine immunizations. According to the World Health Organization and a new study, while timely vaccination is still strongly encouraged, the age restriction should be removed in countries where disease burden is high and delays in vaccinations and deaths from rotavirus are common.

Read the full article.

AlertNet, October 2012

The London School of Tropical Medicine and Hygiene and SHARE, a sanitation and hygiene research initiative funded by the UK's Department of International Development, have co-organized a month-long exhibition on sanitation that features toilet designs, research tools, and yes, a golden poo sculpture.

Read the full article

Yahoo! News, October 2012

Chelsea Clinton is promoting access to ORS and zinc in Nigera, where only 2% of children have access and where 100,000 children die of diarrhea each year. Increasing the number of children with access to ORS and zinc by 80% by 2015 would help prevent an estimated 220,000 deaths in Nigeria.

Read the full article

Every Woman, Every Child, September 2012

At the UN General Assembly, members of the United Nations Commission on Life-Saving Commodities for Women and Children submitted a new plan and set of recommendations to improve access to simple, lifesaving health supplies, including ORS and zinc.

Read the full article

Sabin Vaccine Institute, September 2012

The world's greatest minds focused on defeating rotavirus gathered in Bangkok to share experiences, data, and motivation at overcoming the leading cause of severe childhood diarrhea.

Read the full article

Syndicate content